Literature DB >> 12642829

Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma.

Michael Schatz1, E Francis Cook, Randy Nakahiro, Diana Petitti.   

Abstract

BACKGROUND: The interrelationships between optimal inhaled corticosteroid (IC) therapy, allergy specialist care, and reduced emergency hospital care for asthma have not been well defined.
OBJECTIVE: We sought to evaluate the independent effectiveness of various levels of IC dispensing and allergy specialist care in reducing subsequent emergency asthma hospital use.
METHODS: Asthmatic patients (n = 9608) aged 3 to 64 years were identified from an electronic database of a large health maintenance organization. The outcome was any year 2000 asthma hospitalization or emergency department visit. The main predictors were at least one allergy department visit and the number of IC canisters dispensed in 1999. Analyses were adjusted for age, sex, insurance type, and asthma severity (1999 emergency asthma hospital use, beta-agonist use, and oral corticosteroid use).
RESULTS: Dispensing of 7 or more canisters of ICs (odds ratio [OR], 0.64; 95% CI, 0.43-0.94) and allergy care (OR, 0.73; 95% CI, 0.55-0.97) were associated with reduced subsequent emergency asthma hospital use. More patients with allergy specialist care than those without such care received 7 or more dispensations of ICs (24.7% vs 8.3%, P <.001). When 7 or more dispensations of ICs and allergy specialist care were simultaneously included in an adjusted model, both ICs (OR, 0.68; 95% CI, 0.46-1.00) and allergy care (OR, 0.77; 95% CI, 0.58-1.02) were independently associated with a lower risk of year 2000 emergency asthma hospital care, although significance was borderline.
CONCLUSION: Allergy care reduces emergency hospital use for asthma by increasing use of ICs but probably also has an independent effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642829     DOI: 10.1067/mai.2003.178

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  Patterns of inhaled antiinflammatory medication use in young underserved children with asthma.

Authors:  Arlene M Butz; Mona Tsoukleris; Michele Donithan; Van Doren Hsu; Kim Mudd; Ilene H Zuckerman; Mary E Bollinger
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

2.  Subspecialty differences in asthma characteristics and management.

Authors:  Hubert Chen; Charles A Johnson; Tmirah Haselkorn; June H Lee; Elliot Israel
Journal:  Mayo Clin Proc       Date:  2008-07       Impact factor: 7.616

3.  Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.

Authors:  Ashley Woodcock; Eric D Bateman; William W Busse; Jan Lötvall; Neil G Snowise; Richard Forth; Loretta Jacques; Brett Haumann; Eugene R Bleecker
Journal:  Respir Res       Date:  2011-10-06

4.  Risk factors for asthma-related healthcare use: longitudinal analysis using the NHI claims database in a Korean asthma cohort.

Authors:  Taehoon Lee; Jinhee Kim; Sujeong Kim; Kyoungjoo Kim; Yunjin Park; Yuri Kim; Yoon Su Lee; Hyouk-Soo Kwon; Sae-Hoon Kim; Yoon-Seok Chang; You Sook Cho; An-Soo Jang; Jung-Won Park; Dong-Ho Nahm; Ho-Joo Yoon; Sang-Heon Cho; Young-Joo Cho; Byoung Whui Choi; Hee-Bom Moon; Tae-Bum Kim
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Ethnic disparities in asthma treatment and outcomes in children aged under 15 years in New Zealand: analysis of national databases.

Authors:  Todd D Gillies; Andrew M Tomlin; Susan M Dovey; Murray W Tilyard
Journal:  Prim Care Respir J       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.